In 2023, the United States had the highest male mortality rate from bladder malignant neoplasms, followed by Japan and the United Kingdom. Notably, South Korea and Mexico saw significant year-on-year increases in mortality rate, whereas Canada and Portugal experienced decreases. Over the past five years, the CAGR reveals moderate growth globally in these mortality rates, though regional differences exist. Costa Rica, Iceland, and Luxembourg showed particularly high recent year-on-year changes, indicating potential emerging trends.
Future trends to watch include technological advancements in cancer treatment, public health initiatives aimed at reducing cancer mortality, and demographic changes impacting cancer incidence and outcomes. Regular monitoring of regional health policy impacts and healthcare access disparities will be crucial to understanding how these factors influence mortality rates.
Top countries in Bladder Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 12,250 | 2023 | +0.21% | +0.32% | View data |
| 2 | 2 Japan | 6,600 | 2023 | +1.93% | +2.62% | View data |
| 3 | 3 United Kingdom | 3,980 | 2023 | +0.96% | +1.48% | View data |
| 4 | 4 Germany | 3,900 | 2023 | +0.15% | +0.32% | View data |
| 5 | 5 Spain | 3,530 | 2023 | -0.48% | +0.063% | View data |
| 6 | 6 Brazil | 3,450 | 2023 | +2.59% | +2.85% | View data |
| 7 | 7 Poland | 3,440 | 2023 | +2.14% | +2.28% | View data |
| 8 | 8 Canada | 1,660 | 2023 | +1.03% | -0.31% | View data |
| 9 | 9 Romania | 1,330 | 2023 | +0.99% | +1.2% | View data |
| 10 | 10 South Korea | 1,310 | 2023 | +2.43% | +4.38% | View data |
